CAS: 39028-27-8; 2,5-Dioxopyrrolidin-1-Yl 2-Iodoacetate

该化合物是生物合成应用中常用的异乙基交叉联系试剂. 化合物的特征是NHS 酯类组,能够高效地进行地雷反应结合, 和异丁二醇类有选择地在温和条件下与硫醇类发生反应. 这种双重功能有利于在特定地点对蛋白质,peptides 和其他生物分子进行修改,使其对标签,固定和交叉连接研究具有价值. 亚二甲基基生物组比基于阳性试剂的稳定性更高, 减少不想要的副反应. 使用~ 80%的纯度, 该产品适合在需要精确再活动的情况下对同源工作流程进行控制. 它与水缓冲剂和有机溶剂的兼容性将进一步提高其在各种生物化学和生物技术应用中的效用.

结构式图片

相似化合物

14464-29-0 27243-15-8 42014-51-7

欧盟法规

ECHA物质C&L通报

上下游产品

1-hydroxy-pyrrolidine-2,5-dione Iodoacetic acid1-(N-carbobenzyloxy-L-alanyl-L-alanyl-L-phenylalanyl)-2-iodoacetyl hydrazine 75H99IN26O13C75H99IN26O13 21H29IN4O8C21H29IN4O8 1,3,5-tris(iodoacetamidomethyl)-2,4,6-triethylbenzene

合成工艺路线路线简述

    N-羟基丁二酰亚胺,碘乙酸置于n,N'-二异丙基碳二亚胺体系中,用 乙酸乙酯 作为反应溶剂,化学反应 6.0H,以86%的收率获得产物碘乙酸 N-羟基琥珀酰亚胺酯
    参考文献:易于操作的phospho标记荧光香豆素,可通过质谱增强结合物的检测†
    标题:易于操作的phospho标记荧光香豆素,可通过质谱增强结合物的检测†
    摘要:荧光香豆素是一类重要的小分子有机荧光团,在不同的成熟和新兴研究领域中普遍存在,其中包括生物化学和化学生物学.目前的工作旨在通过质谱法研究基于香豆素的结合物的可检测性差,同时保持香豆素核心的重要光物理性质.在这种情况下,已经报道了易于功能化的带有-标记的香豆素衍生物的合成,该合成的香豆素衍生物能够通过一步操作对目标分析物或(生物)分子进行双重质量标记和荧光标记.这些香豆素的用途通过荧光底物的制备来说明,该底物有助于鉴定由特异性蛋白水解裂解释放的肽片段.
    DOI:10.1039/c6Ob01080F

    海关参考信息

    专利信息


    专利号:WO-2024186075-A1
    优先权日:2023-03-03
    标题 :Synthesis method of antibody-drug conjugates using proximity effect-based site-selective antibody labeling
    发明人:LEE HYUN SOO; KIM SOOIN; KWEON YONGSEOK
    权利人:UNIV SOGANG RES & BUSINESS DEVELOPMENT FOUND; RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIV
    摘要:The present invention relates to a method for the synthesis of an antibody-drug conjugate using proximity effect-based site-selective antibody labeling. Provided according to the present invention may be a method for the synthesis of an antibody-drug conjugate by site-selectively introducing a drug into an antibody using a pyridinium oxime derivative (labeling mediator protein) introduced into a binding protein containing a non-standard amino acid.

    专利号:US-10254287-B2
    优先权日:2015-07-21
    标题 :Protein fluorescent nanoparticles and methods of synthesis thereof
    发明人:KUMAR CHALLA VIJAYA; STROMER BOBBI SHANYELLE
    权利人:UNIV CONNECTICUT
    摘要:Disclosed herein are stable and versatile protein nanoparticles having a range of tunable fluorescent properties. Such nanoparticles may find utility in biological imaging. Methods of synthesis of such nanoparticles are also disclosed.

    专利号:US-12195343-B2
    优先权日:2019-10-15
    标 题 :Synthesis of janus nanomaterials
    发明人:WANG WEI
    权利人:SAUDI ARABIAN OIL CO
    摘要:Synthesizing Janus nanoparticles including forming a lamellar phase having water layers, organic layers, and a surfactant, and reacting chemical precursors in the lamellar phase to form the Janus nanoparticles at interfaces of the water layers with the organic layers.

    专利号:US-9012648-B2
    优先权日:2012-08-21
    标题 :Haptens of risperidone and paliperidone
    发明人:HASPESLAGH PIETER RIK; VLIEGEN MAARTEN; HRYHORENKO ERIC; DECORY THOMAS R; SANKARAN BANUMATHI
    权利人:JANSSEN PHARMACEUTICA NV; ORTHO CLINICAL DIAGNOSTICS INC
    摘要:The invention relates to compounds of Formula I, wherein R1 and R2 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from risperidone and paliperidone. The invention also relates to conjugates of a risperidone or paliperidone hapten and a protein.

    专利号:US-9303041-B2
    优先权日:2012-08-21
    标题 :Haptens of olanzapine
    发明人:DONAHUE MATTHEW GARRETT; GONG YONG; SALTER RHYS; HRYHORENKO ERIC; DECORY THOMAS R; REMMERIE BART; SANKARAN BANUMATHI
    权利人:JANSSEN PHARMACEUTICA NV; ORTHO CLINICAL DIAGNOSTICS INC
    摘要:The invention relates to compounds of Formula I, wherein R 1 , R 2 , and R 3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from olanzapine. The invention also relates to conjugates of an olanzapine hapten and a protein.

    专利号:US-9795685-B2
    优先权日:2012-08-21
    标 题 :Haptens of aripiprazole
    发明人:LIN RONGHUI; SALTER RHYS; DECORY THOMAS R; HRYHORENKO ERIC; REMMERIE BART M; SANKARAN BANUMATHI
    权利人:JANSSEN PHARMACEUTICA NV
    摘要:The invention relates to compounds of Formula I, wherein R 1 , R 2 , and R 3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
    常州安赛普化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ansciepchem.com
    企业联系电话:0519-86305871👤
    📞常州安赛普化工有限公司 ⚠️参考联系方式
    联系人:程经理
    电话:0519-86305871

    传真:qq:2719466718
    邮箱:info@ansciepchem.com
    通信地址: 江苏省常州市武进区科教城天鸿科技大厦A座1012室
    邮编: 213161
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市武进区科教城天鸿科技大厦A座1012室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Piñero DP, Alio JL, Klonowski P, Toffaha B. Vectorial astigmatic changes after corneal collagen crosslinking in keratoconic corneas previously treated with intracorneal ring segments: a preliminary study. Eur J Ophthalmol. 2012;22 Suppl
    7:S69-80. doi: 10.5301/ejo.5000063.
    3: Zhang M, Varki A. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis. Glycobiology. 2004 Nov;14(11):939-49. Epub 2004 Jul 7. doi: 10.1039/c3lc51247a.

    合成参考文献


    参考文献:10.1007/978-1-60327-299-5_18
    摘要:McIntyre JO, Scherer RL, Matrisian LM. Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods Mol Biol. 2010;622():279–304.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知